PEGylation of Nanocarriers & Nanoparticles

Need Custom PEGylated Nanoparticles & Nanocarriers? Let BOC Sciences Help

BOC Sciences offers a wide range of PEGylated nanoparticles & nanocarriers, covering lipid-based, polymeric, inorganic, and biological nanocarriers. Through PEG modification, we enhance circulation time, reduce immune clearance, optimize drug release, and support targeted delivery. Whether for basic research, drug development, or preclinical studies, BOC Sciences provides comprehensive, customized PEGylation services.

PEGylated Lipid Nanoparticles

• Custom preparation of PEGylated solid lipid nanoparticles, gold nanoparticles, and nanoemulsions.
• Efficient encapsulation of small molecules, nucleic acids (mRNA/siRNA), and protein therapeutics.
• Enable long-circulation stability and passive/active targeted delivery.
• Offer surface ligand conjugation, particle size control, and release profile optimization.

PEGylated Liposomes

• Provide various PEGylated liposomes, including unilamellar and multilamellar structures.
• Encapsulate hydrophobic and hydrophilic drugs with sustained and controlled release.
• Support active targeting modifications, such as antibodies, sugar ligands, or small molecule conjugates.
• Comprehensive characterization of particle size, surface charge, and PEGylation efficiency.

PEGylated Polymeric Nanoparticles

• PEGylation of degradable and non-degradable polymeric nanoparticles (nanocapsules, nanospheres).
• Encapsulation of small molecules and biomacromolecules (proteins, peptides).
• Adjustable PEG chain length, modification density, and drug release rate.
• Pilot-scale and cGMP-grade production capabilities for R&D to commercialization.

PEGylated Inorganic Nanoparticles

• PEGylation of gold nanoparticles, silica nanoparticles, magnetic nanoparticles, and more.
• Supports drug loading and surface ligand functionalization for targeted delivery and diagnostic imaging.
• Adjustable particle size, surface charge, and PEG density to optimize biodistribution.
• Characterization services including TEM, DLS, zeta potential, and drug release testing.

PEGylated Micelles

• PEGylated amphiphilic polymeric micelles and lipid-based micelles.
• Effective loading of hydrophobic drugs or photosensitizers with controlled release.
• Adjustable PEG chain length and surface functionalization for optimized circulation and targeting.
• In vitro release, stability, and particle size distribution characterization services.

PEGylated Biological Nanocarriers

• PEGylated exosomes, protein nanoparticles, and virus-like particles (VLPs).
• Supports delivery of proteins, nucleic acids, and small molecule drugs.
• Natural targeting capability with reduced immunogenicity and prolonged circulation.
• Surface functionalization, drug loading optimization, and stability assessment services.

Expert PEGylated Nanoparticles & Nanocarriers Solutions

In drug delivery research, nanocarrier surface modification directly affects circulation time, targeting efficiency, and drug release performance. BOC Sciences offers professional PEGylation solutions, providing end-to-end custom services from carrier design to drug encapsulation, ensuring optimal delivery performance and research efficiency.

Custom Nanocarrier Surface Design

BOC Sciences has extensive experience in nanocarrier design and can provide tailored PEGylation strategies based on drug properties, targeting requirements, and release mechanisms. Services include:

• Selection of PEG chain length and molecular weight (e.g., 2kDa, 5kDa, 10kDa).
• Optimization of PEG modification density and spatial configuration.
• Functionalized PEG termini (e.g., carboxyl, amino, thiol) for subsequent ligand or drug conjugation.

Nanocarrier Preparation Services

BOC Sciences offers a range of nanocarrier preparation techniques to ensure uniform particle size, controllable morphology, and compatibility with various drug types. Services include:

• Lipid-Based Carrier Preparation: Thin-film hydration, ultrasonic emulsification, high-pressure homogenization.
• Polymeric Carrier Preparation: Solvent evaporation, nanoprecipitation, self-assembly.
• Inorganic & Biological Carrier Preparation: Sol-gel method, chemical reduction, and exosome isolation.

PEGylation Chemistry & Preparation

BOC Sciences provides diverse PEG modification methods to ensure stable, controllable, and reproducible nanocarrier surface modification. Services include:

• Covalent modifications (esterification, amidation, click chemistry) for long-term stability.
• Non-covalent modifications (hydrophobic, electrostatic interactions) suitable for controlled release.
• Multifunctional PEG modifications to support subsequent ligand or drug conjugation.

Drug Loading & Encapsulation Optimization

For different drug types, BOC Sciences offers efficient loading and encapsulation solutions, ensuring stable drug delivery within nanocarriers. Services include:

• High-efficiency encapsulation of small molecules, macromolecules, and hydrophobic/hydrophilic drugs.
• Optimizing drug loading for sustained and controlled release.
• Control of drug distribution on surface or within carriers to meet various delivery needs.

Nanocarrier Quality Control & Characterization Services

Nanocarriers offer several advantages over traditional drug therapies because their size, charge, surface properties, and targeting moieties are more easily tailored to modulate their uptake, biodistribution, targeting, and elimination. They can be administered by many different routes, such as parenteral, nasal, topical or oral routes. Owing to the above-mentioned advantages, there is an increasing need to develop nanocarriers with broad properties targeting various diseases. Based on this, BOC Sciences offers PEGylated nanocarrier characterization services covering a comprehensive range of techniques for evaluating and optimizing the properties of nanocarriers for various applications in drug delivery.

Leading Technical Capabilities & Service Excellence

• Professional R&D Team: Our team of biochemistry, pharmaceutics, and nanomaterials experts integrates cutting-edge research to provide scientifically sound PEGylation nanocarrier solutions, ensuring maximized drug delivery performance.
• Custom Design Capability: We optimize PEG chain length, density, and terminal functionality according to drug type, targeting requirements, and release mechanisms to achieve the best match between nanocarrier performance and drug delivery efficiency.
• Compatibility with Multiple Nanocarrier Types: We support PEGylation of lipid, polymeric, inorganic, and biological nanocarriers, meeting diverse drug development needs while flexibly adjusting carrier structure and surface properties.
• Strict Quality Control: Full-process characterization, including particle size, surface charge, drug loading, and PEGylation efficiency, ensures stable, consistent product performance in line with R&D and preclinical standards.
• Integrated R&D to Production: From laboratory development to pilot-scale scale-up and cGMP-grade production, we provide end-to-end support, offering an integrated solution from research to preclinical validation.
• Efficient Customer Support: Professional technical consultation, project management, and after-sales service ensure PEGylated nanocarrier projects are completed on time and to high quality, providing personalized R&D guidance.
• Safety and Compliance Assurance: Strict adherence to cGMP, pharmacopeia, and relevant regulations ensures nanocarrier products are safe and reliable throughout preparation, characterization, and application, meeting international drug development standards.

Service Workflow and Project Management

A systematic service workflow is key to achieving effective drug delivery and project success in nanocarrier PEGylation projects. BOC Sciences provides end-to-end services from project consultation, carrier design, and laboratory preparation to characterization, scale-up production, and post-project technical support, ensuring each step is precisely controlled to meet different R&D stages and application requirements.

Project Consultation & Needs Analysis

Clients provide drug information, targeting applications, and nanocarrier types. BOC Sciences conducts feasibility assessments based on cutting-edge research experience and proposes scientifically sound PEGylation strategies to guide subsequent design.

Carrier Design & PEGylation Plan Development

Based on project requirements, we determine nanocarrier type, PEG chain length and molecular weight, terminal functionality, and modification method, optimizing surface properties to achieve the best design for targeted delivery, sustained, and controlled release.

Laboratory Preparation & Optimization

PEGylation modifications are performed under laboratory conditions, optimizing particle size, drug loading, and surface properties to ensure high stability, controllable drug release, and excellent biocompatibility of nanocarriers.

Characterization & Quality Assessment

Comprehensive quality characterization is provided, including particle size distribution, surface charge, PEGylation efficiency, and drug release profiles, ensuring each batch meets consistent performance standards for R&D and preclinical studies.

Pilot-Scale & Large-Scale Production

Depending on client R&D stage and production needs, pilot-scale scale-up and reproducible manufacturing processes are provided to maintain consistent particle size, stability, and drug loading across different scales.

Technical Support & After-Sales Service

We provide data analysis, experimental result interpretation, and application guidance. Customized follow-up services are also available, ensuring smooth project progression and supporting technical optimization during R&D.

Exploring the Applications of PEGylated Nanoparticles & Nanocarriers

PEGylation of nanoparticles and nanocarriers significantly extends blood circulation, reduces immune clearance, and improves drug stability and targeting. BOC Sciences provides customized PEGylation services to support diverse drug delivery and preclinical research applications, meeting needs from basic research to precision medicine.

Anti-Cancer Drug Delivery

PEGylated nanocarriers enable active or passive targeting to tumors via the enhanced permeability and retention (EPR) effect. PEG forms a hydrophilic barrier that prolongs circulation, reduces immune clearance, increases drug accumulation at tumor sites, enhancing efficacy while minimizing toxicity to healthy tissues.

Gene & Nucleic Acid Delivery

PEGylated nanocarriers effectively protect nucleic acid drugs, such as siRNA, mRNA, and DNA, from enzymatic degradation and enhance cellular uptake. PEG reduces immunogenicity and prolongs circulation, facilitating stable delivery of nucleic acids to target cells for gene expression regulation or therapy.

Protein & Peptide Drug Delivery

PEGylated nanocarriers protect proteins and peptides from enzymatic degradation or rapid clearance, extending half-life. PEG reduces immune recognition, improves biocompatibility, and controls drug release rates, ensuring stable delivery to target tissues, enhancing efficacy, and minimizing immune reactions.

Diagnostics & Imaging

PEGylated nanocarriers are used in medical imaging and diagnostics, including MRI, fluorescence imaging, and photoacoustic imaging. PEG enhances blood stability, reduces nonspecific adsorption, and, combined with targeting modifications, increases accumulation in lesions or specific tissues for improved contrast and diagnostic accuracy.

Multifunctional Combination Therapy

PEGylated nanocarriers enable co-delivery of chemotherapeutics, photosensitizers, or photothermal agents for multi-modal therapy. The PEG layer prolongs circulation, reduces immune clearance, and provides a controlled release platform for drug combinations, achieving synergistic chemotherapy, photothermal, or photodynamic effects with reduced side effects.

Tissue Engineering & Regenerative Medicine

In tissue engineering and regenerative medicine, PEGylated nanocarriers serve as carriers for growth factors, signaling molecules, or drugs, enabling targeted and controlled release. PEG enhances biocompatibility and stability, ensuring sustained release of active factors to promote cell proliferation, differentiation, and tissue regeneration, supporting tissue repair and regenerative research.

Frequently Asked Questions

Still have questions?

Contact Us

• What are nanocarriers?

  Nanocarriers (10-100 nm) are drug delivery systems that utilize nanoparticles to transport and release therapeutic agents to specific target sites in the body. The potential uses and efficacy of various nanodrug carriers for anticancer drugs are much higher than those of ordinary nanodrug carriers. Nanocarriers offer several advantages over traditional drug delivery systems, such as extended plasma half-life, improved biodistribution, and targeted delivery of drugs to the tumor microenvironment through the endothelium. These nanocarrier-based drug delivery systems are used to combat various types of cancerous tumors containing tissue. Nanocarriers come in various forms, such as liposomes, polymeric nanoparticles, micelles, dendrimers, and solid lipid nanoparticles, each with its own unique properties and advantages.

• What are PEGylated nanoparticles?

  PEGylated nanoparticles are nanoparticles that have been modified by attaching polyethylene glycol (PEG) chains to their surface. This "PEGylation" improves their stability, solubility, and biocompatibility, reduces immune recognition, and prolongs circulation time in the body. They are widely used in drug delivery, imaging, and therapeutic applications to enhance performance and reduce side effects.

• What is the mechanism of action of polyethylene glycol?

  All nanoparticles (NPs) contain at least two basic spatial components: core and corona, which interact with the environment or solvent. Core/multi-shell systems add further complexity when in the core-shell configuration, for example, all core/multi-shell systems still have regions at the NP-solvent interface. PEG chains alter this interfacial layer and increase cycle time. Circulating half-life (t ½ ) describes the blood pool residence time and is the time during which the nanoparticle concentration in the circulation remains above 50% of the injected dose, similar to the half-life of a drug. Nanoparticle efficacy requires a sufficient t½ not only to reach the target but also to remain in the affected area (at a concentration sufficiently above background tissue) long enough to allow for image capture or drug delivery. The reticuloendothelial system (RES) prevents accumulation at specific sites because it removes nanoparticles from circulation, thereby acting as competitors for the intended target site. Additionally, nanoparticles must be cleared from non-target areas to produce imaging contrast or dose efficiency.

• What is PEGylated polymeric nanoparticle?

  Biodegradable polymeric nanoparticles have many advantages for drug delivery, such as controlled release and targeting. However, after intravenous administration of polymeric nanoparticles, they will be cleared by the endothelial reticulum system within a few seconds or minutes. In order to overcome this shortcoming, hydrophilic PEG is introduced to modify the polymer. The introduction of PEG will not only affect the biodegradation behavior of nanoparticles, but also affect the release and distribution of drugs in the body. Polymeric nanoparticles are usually PEGylated by (1) physical surface coverage with PEG or PEG derivatives, (2) preparation of nanoparticles with PEG block co-polymers and (3) grafting PEG onto the nanoparticles surface.

• What is PEGylated inorganic nanoparticle?

  Inorganic nanoparticles made of calcium phosphate, gold, silica and iron oxide are preferred for drug delivery due to ease of preparation and uniform size and amenability for surface functionalization. However, these are less stable and could be toxic in biological systems. Therefore, in order to improve the biological stability and biocompatibility, surface modification has been carried out with PEG.

• What is PEGylated liposome?

  Liposome is an ideal drug delivery carrier. It has targeted properties, longer blood retention time and higher organ distribution selectivity, can improve the efficacy of drugs and reduce toxic side effects. Ordinary liposomes have the disadvantage of being easily cleared from the systemic circulation by liver and spleen macrophages. In this case, PEGylation can solve the above shortcomings, making liposomes stay in the blood for a longer time and increasing the passive targeting function of drugs. Moreover, it is simple to prepare PEG-phospholipid derivatives in advance, which has become the current research focus of PEGylation technique.

• What is PEGylated micelle?

  Micelles are frequently preferred choice for anticancer drug delivery. Preparation of PEGylated micelles mostly utilizes PEGylated polymers or lipids through synthetic approaches. Block copolymer micelles with PEG coronas have emerged as systems with great potential in drug delivery, as they combine biocompatibility with the synthetic versatility of PEG. A variety of activated PEGs can be used exploited for these systems, such as block copolymer structures, providing control over the type and stability of covalent.

Case Studies and Success Stories

Publications

This section showcases the academic achievements of international research teams using BOC Sciences' products and services, highlighting our industry impact in lipid and PEG supply and development.

• Baricitinib Liposomes as a New Approach for the Treatment of Sjögren's Syndrome. Pharmaceutics 14.9 (2022): 1895. PMID: 36145642 DOI: 10.3390/pharmaceutics14091895.
• Super-tough sustainable biobased composites from polylactide bioplastic and lignin for bio-elastomer application. Polymer 212 (2021): 123153. DOI: 10.1016/j.polymer.2020.123153.
• A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor-β signaling. American Journal of Cancer Research 12.2 (2022): 763. PMID: 35261800.
• Liquid chromatography–tandem mass spectrometry method for the analysis of N-(3-aminopropyl)-N-dodecylpropane-1, 3-diamine, a biocidal disinfectant, in dairy products. Food chemistry 262 (2018): 168-177. DOI: 10.1016/j.foodchem.2018.04.080.
• Oleanolic Acid Promotes Neuronal Differentiation and Histone Deacetylase 5 Phosphorylation in Rat Hippocampal Neurons . Molecules and cells 40.7 (2017): 485. PMID: 28681592 DOI: 10.14348/molcells.2017.0034.

Client Testimonials

Industry Distribution of Custom Lipid Synthesis Clients

"Developing PEGylated PLGA nanoparticles for protein delivery was challenging due to stability and release profile requirements. BOC Sciences delivered uniform, high-quality nanoparticles and provided expert guidance on formulation optimization."

— Dr. Laura Mitchell, Senior Formulation Scientist (USA)

"We needed DSPE-PEG-modified lipid nanoparticles for mRNA vaccine delivery. BOC Sciences supplied high-purity PEG-lipids and helped optimize nanoparticle preparation, significantly improving circulation time and stability."

— Mr. Erik Johansson, Nanomedicine Researcher (Sweden)

"BOC Sciences' PEGylation expertise allowed us to rapidly prototype multifunctional PEGylated nanocarriers. Their technical support and quality control were outstanding, ensuring reproducible results for preclinical studies."

— Dr. Sophie Müller, Drug Delivery Scientist (Germany)

"Scaling up PEGylated nanoparticles for in vivo studies required precise control over size and PEG density. BOC Sciences delivered consistent, cGMP-grade materials with detailed characterization and documentation."

— Mr. James O'Connor, Pharmacokinetics Scientist (UK)